Potent TLR1/2 agonist (EC50 = 52.9 nM). Activates the NF-κB pathway and upregulates proinflammatory cytokines in vitro. Also enhances TLR1 and TLR2 dimerization.
Sold under license from the University of Colorado
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 362.31. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.76 mL||13.8 mL||27.6 mL|
|5 mM||0.55 mL||2.76 mL||5.52 mL|
|10 mM||0.28 mL||1.38 mL||2.76 mL|
|50 mM||0.06 mL||0.28 mL||0.55 mL|
References are publications that support the products' biological activity.
Cheng et al (2013) Discovery of small molecule inhibitors of the TLR1-TLR2 complex. Angew.Chem.Int.Ed.Engl. 51 12246 PMID: 22969053
Cheng et al (2015) Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists Sci.Adv. 1 e1400139 PMID: 26101787
If you know of a relevant reference for CU-T12-9, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: CU-T12-9, supplier, Potent, TLR1/2, activators, activates, Toll-like, Receptors, Toll-like, Receptors, Tocris Bioscience
Citations for CU-T12-9
Citations are publications that use Tocris products.
Currently there are no citations for CU-T12-9. Do you know of a great paper that uses CU-T12-9 from Tocris? If so please let us know.
Average Rating:(Based on 0 Reviews)